Table 2.
Twenty-eight-day mortality rate data of patients with ARDS from COVID-19
| Authors, Year of Publication [Reference] | Study Period | City, Country | Mortality |
|---|---|---|---|
| Yang et al,69 2020 | 12/24/2019–01/26/2020 | Wuhan, China | 61.5% |
| Wang et al,70 2020 | 01/25/2020–02/25/2020 | Shanghai, China | 88.3% |
| Grasselli et al,71 2020 | 02/20/2020–03/18/2020 | Milan, Italy | 26% |
| Ferrando et al,72 2020 | 03/12/2020–06/01/2020 | Spain and Andora | 36% |
| Bhatraju et al,74 2020 | 02/24/2020–03/09/2020 | Seattle, USA | 50%∗ |
| Gupta et al,73 2020 | 03/04/2020–04/04/2020 | Various cities, USA | 6.6%-80.8% (35.4%) |
All patients were admitted to the ICU with ARDS due to COVID-19. All mortalities are 28-d mortality except the study by ∗Batraju et al which includes a 14-d mortality.